Cargando…

Effect of large dosage of Fuling on urinary protein of diabetic nephropathy: A protocol of systematic review and meta-analysis of randomized clinical trials

INTRODUCTION: Diabetic nephropathy (DN) is one of the most common and serious microvascular complications in patients with diabetes, which seriously affects their life quality and survival time. large dose herb Fuling or compound prescription contain large dose Fuling for treatment of DN has already...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Jia, Zhang, Li, Zhang, Xinxia, Wang, Lizhen, Yang, Botong, Chen, Qi, Zhong, Min, Tang, Xiaoming, Zhou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535777/
https://www.ncbi.nlm.nih.gov/pubmed/33019413
http://dx.doi.org/10.1097/MD.0000000000022377
_version_ 1783590457446498304
author Xia, Jia
Zhang, Li
Zhang, Xinxia
Wang, Lizhen
Yang, Botong
Chen, Qi
Zhong, Min
Tang, Xiaoming
Zhou, Jun
author_facet Xia, Jia
Zhang, Li
Zhang, Xinxia
Wang, Lizhen
Yang, Botong
Chen, Qi
Zhong, Min
Tang, Xiaoming
Zhou, Jun
author_sort Xia, Jia
collection PubMed
description INTRODUCTION: Diabetic nephropathy (DN) is one of the most common and serious microvascular complications in patients with diabetes, which seriously affects their life quality and survival time. large dose herb Fuling or compound prescription contain large dose Fuling for treatment of DN has already been confirmed. However, due to the lack of evidence, there is no specific method or suggestion, so it is necessary to carry out systematic evaluation on Fuling and provide effective evidence for further research. METHODS AND ANALYSIS: The following databases will be searched from their inception to June 2020: Electronic database includes PubMed, Embase, Cochrane Library, Web of Science, Nature, Science online, Chinese Biomedical Database WangFang, VIP medicine information, and China National Knowledge Infrastructure (CNKI). Primary outcomes:24-hurinary-albumin, Urinary albumin-to-creatinine ratio. Additional outcomes: Serum creatinine, Blood urea nitrogen, Glomerular filtration rate, Endogenous creatinine clearance rate. Data will be extracted by 2 researchers independently, risk of bias of the meta-analysis will be evaluated based on the Cochrane Handbook for Systematic Reviews of Interventions. All data analysis will be conducted by data statistics software Review Manager V.5.3. and Stata V.12.0. RESULTS: The results of this study will systematically evaluate the effectiveness and safety of large dose Fuling intervention for people with DN. CONCLUSION: The systematic review of this study will summarize the current published evidence of large dose Fuling for the treatment of DN, which can further guide the promotion and application of it. ETHICS AND DISSEMINATION: This study is a systematic review, the outcomes are based on the published evidence, so examination and agreement by the ethics committee are not required in this study. We intend to publish the study results in a journal or conference presentations. OPEN SCIENCE FRAMEWORK (OSF) REGISTRATION NUMBER: August 24, 2020. osf.io/ym2c6. (https://osf.io/ym2c6).
format Online
Article
Text
id pubmed-7535777
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75357772020-10-14 Effect of large dosage of Fuling on urinary protein of diabetic nephropathy: A protocol of systematic review and meta-analysis of randomized clinical trials Xia, Jia Zhang, Li Zhang, Xinxia Wang, Lizhen Yang, Botong Chen, Qi Zhong, Min Tang, Xiaoming Zhou, Jun Medicine (Baltimore) 4300 INTRODUCTION: Diabetic nephropathy (DN) is one of the most common and serious microvascular complications in patients with diabetes, which seriously affects their life quality and survival time. large dose herb Fuling or compound prescription contain large dose Fuling for treatment of DN has already been confirmed. However, due to the lack of evidence, there is no specific method or suggestion, so it is necessary to carry out systematic evaluation on Fuling and provide effective evidence for further research. METHODS AND ANALYSIS: The following databases will be searched from their inception to June 2020: Electronic database includes PubMed, Embase, Cochrane Library, Web of Science, Nature, Science online, Chinese Biomedical Database WangFang, VIP medicine information, and China National Knowledge Infrastructure (CNKI). Primary outcomes:24-hurinary-albumin, Urinary albumin-to-creatinine ratio. Additional outcomes: Serum creatinine, Blood urea nitrogen, Glomerular filtration rate, Endogenous creatinine clearance rate. Data will be extracted by 2 researchers independently, risk of bias of the meta-analysis will be evaluated based on the Cochrane Handbook for Systematic Reviews of Interventions. All data analysis will be conducted by data statistics software Review Manager V.5.3. and Stata V.12.0. RESULTS: The results of this study will systematically evaluate the effectiveness and safety of large dose Fuling intervention for people with DN. CONCLUSION: The systematic review of this study will summarize the current published evidence of large dose Fuling for the treatment of DN, which can further guide the promotion and application of it. ETHICS AND DISSEMINATION: This study is a systematic review, the outcomes are based on the published evidence, so examination and agreement by the ethics committee are not required in this study. We intend to publish the study results in a journal or conference presentations. OPEN SCIENCE FRAMEWORK (OSF) REGISTRATION NUMBER: August 24, 2020. osf.io/ym2c6. (https://osf.io/ym2c6). Lippincott Williams & Wilkins 2020-10-02 /pmc/articles/PMC7535777/ /pubmed/33019413 http://dx.doi.org/10.1097/MD.0000000000022377 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4300
Xia, Jia
Zhang, Li
Zhang, Xinxia
Wang, Lizhen
Yang, Botong
Chen, Qi
Zhong, Min
Tang, Xiaoming
Zhou, Jun
Effect of large dosage of Fuling on urinary protein of diabetic nephropathy: A protocol of systematic review and meta-analysis of randomized clinical trials
title Effect of large dosage of Fuling on urinary protein of diabetic nephropathy: A protocol of systematic review and meta-analysis of randomized clinical trials
title_full Effect of large dosage of Fuling on urinary protein of diabetic nephropathy: A protocol of systematic review and meta-analysis of randomized clinical trials
title_fullStr Effect of large dosage of Fuling on urinary protein of diabetic nephropathy: A protocol of systematic review and meta-analysis of randomized clinical trials
title_full_unstemmed Effect of large dosage of Fuling on urinary protein of diabetic nephropathy: A protocol of systematic review and meta-analysis of randomized clinical trials
title_short Effect of large dosage of Fuling on urinary protein of diabetic nephropathy: A protocol of systematic review and meta-analysis of randomized clinical trials
title_sort effect of large dosage of fuling on urinary protein of diabetic nephropathy: a protocol of systematic review and meta-analysis of randomized clinical trials
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535777/
https://www.ncbi.nlm.nih.gov/pubmed/33019413
http://dx.doi.org/10.1097/MD.0000000000022377
work_keys_str_mv AT xiajia effectoflargedosageoffulingonurinaryproteinofdiabeticnephropathyaprotocolofsystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT zhangli effectoflargedosageoffulingonurinaryproteinofdiabeticnephropathyaprotocolofsystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT zhangxinxia effectoflargedosageoffulingonurinaryproteinofdiabeticnephropathyaprotocolofsystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT wanglizhen effectoflargedosageoffulingonurinaryproteinofdiabeticnephropathyaprotocolofsystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT yangbotong effectoflargedosageoffulingonurinaryproteinofdiabeticnephropathyaprotocolofsystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT chenqi effectoflargedosageoffulingonurinaryproteinofdiabeticnephropathyaprotocolofsystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT zhongmin effectoflargedosageoffulingonurinaryproteinofdiabeticnephropathyaprotocolofsystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT tangxiaoming effectoflargedosageoffulingonurinaryproteinofdiabeticnephropathyaprotocolofsystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT zhoujun effectoflargedosageoffulingonurinaryproteinofdiabeticnephropathyaprotocolofsystematicreviewandmetaanalysisofrandomizedclinicaltrials